In the systemic sclerosis condition, activation of TLR4–TRAF6–NF-κB signaling and subsequent induction of TGF-β promote fibroblast activation and extracellular matrix (ECM) deposition, leading to excessive collagen and α-SMA expression. This evidence concerns the gene TGFB1 and systemic sclerosis.